Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2052660

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2052660

Virtual Clinical Trials Market, By Study Type, By Phases, By Company Size, By Therapeutic Area, and By Geography

PUBLISHED:
PAGES: 161 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Virtual Clinical Trials Market is estimated to be valued at USD 4,339.2 Mn in 2026 and is expected to reach USD 13,700.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 17.9%USD 13,700.0 Mn from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 4,339.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 17.90% 2033 Value Projection: USD 13,700 Mn

Virtual clinical trials is a relatively new method of conducting clinical research using technologies and online social engagement platforms. Virtual trials have the potential to drive significant digital alterations in the clinical research methodologies to create an improved patient-centric ecosystem. Virtual clinical trials are digitally empowered the clinical trial process.

Market Dynamics

Growing burden of diseases, spike in virtual clinical trials adoption, rise in adoption of telehealth, rise in adoption of novel technologies, rise in healthcare digitization, technological advancements, and the outbreak of COVID-19 (pandemic) are major factors expected to boost the growth of the global virtual clinical trials market during the forecast period.

For instance, in November 2019, Johnson & Johnson in collaboration with PRA Health Sciences, launched the clinical trial set-up CHIEF-HF, a completely decentralize, indication-seeking, mobile clinical study. The company aims to utilize wearable devices and smart technology to efficiently gather and analyze evidence for assessing effectiveness of Canagliflozin in the populace with heart failure with presence of absence of type 2 diabetes.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global virtual clinical trials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Delve Health, Clario, Clinical Ink, Castor, Accenture, Thread, Science 37, Medable, Dassault Systemes, and eElinicalHealth (CLINPAL), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global virtual clinical trials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global virtual clinical trials market.

Market Segmentation

  • Global Virtual Clinical Trials Market, By Study Type (Revenue, USD Mn, 2021 - 2033)
  • Interventional
  • Others
  • Global Virtual Clinical Trials Market, By Phases (Revenue, USD Mn, 2021 - 2033)
  • Late Stage
  • Early Stage
  • Global Virtual Clinical Trials Market, By Company Size (Revenue, USD Mn, 2021 - 2033)
  • Small- & Mid-sized
  • Large-sized
  • Global Virtual Clinical Trials Market, By Therapeutic Area (Revenue, USD Mn, 2021 - 2033)
  • Oncology
  • Rare & Genetic Diseases
  • CNS
  • Immunology
  • Others
  • Global Virtual Clinical Trials Market, By Geography (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Delve Health
  • Clario
  • Clinical Ink
  • Castor
  • Accenture
  • Thread
  • Science 37
  • Medable
  • Dassault Systemes
  • eElinicalHealth (CLINPAL)
Product Code: CMI5658

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Study Type
    • Market Snapshot, By Phases
    • Market Snapshot, By Company Size
    • Market Snapshot, By Therapeutic Area
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in number of virtual clinical trials worldwide
    • Challenges associated with virtual clinical trials
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Virtual Clinical Trials Market, By Study Type, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Interventional
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

5. Global Virtual Clinical Trials Market, By Phases, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Late Stage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Early Stage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

6. Global Virtual Clinical Trials Market, By Company Size, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Small- & Mid-sized
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Large-sized
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

7. Global Virtual Clinical Trials Market, By Therapeutic Area, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Rare & Genetic Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • CNS
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)

8. Global Virtual Clinical Trials Market, By Geography, 2021 - 2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2021 - 2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2021 - 2033, (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Delve Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Clario
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Clinical Ink
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Castor
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Accenture
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thread
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Science 37
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medable
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dassault Systemes
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • eElinicalHealth (CLINPAL)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!